Please CLICK HERE to join our email list for updates on our program and speakers and for opening of registration.
TARGETING METABESITY 2022
October 10-13, 2022
Michael Zemel, PhD
Founder and Chief Scientific Officer of NuSirt Biopharma, USA
Dr. Michael Zemel is founder and CSO of NuSirt Biopharma, where he leads research programs focused on energy-sensing and development of therapeutics for diseases of aging and over-nutrition. Previously, he was Professor of Nutrition and of Medicine at the University of Tennessee from 1990-2012, where his work focused on energy sensing, muscle-fat cross-talk, and regulation of adipocyte metabolism. Prior to the University of Tennessee, he served on the faculties of Endocrinology and of Nutrition at Wayne State University and as Research Endocrinologist at the VA Medical Center associated with Wayne State from 1980-1990, where his work focused on endocrine regulation of cell signaling and downstream effects on both blood pressure regulation and insulin sensitivity. He founded NuSirt Biopharma in 2007.
Dr. Zemel received his PhD in Physiology and Nutrition at the University of Wisconsin-Madison.